Resilience

Attending the American Biomanufacturing Summit? Be sure to attend our lunch and learn session to discuss “Accelerating Biologics to the Clinic While Assuring Commercial Success” to learn how Resilience’s expertise in biomanufacturing can help streamline your pathway to commercialization—without compromising quality or speed. Learn more at: https://hubs.ly/Q03fh9Dp0 #BioUS25 #GenerisBIO #Biologics

Putting down roots with a CDMO partner is a big decision, and we want to ensure you can do it with confidence. Your product has its own unique growth curve, and determining if our manufacturing capacity and expertise is the right fit, is essential. We invite you to take our innovative questionnaire to discover which of our services might align with your drug product scale-up needs. At the end, you’ll receive a customized list of resources to help guide you through to your next phase. Learn more today: https://hubs.ly/Q0361RC_0

We’re excited to connect with biomanufacturing leaders, innovators, and partners to discuss how we can accelerate your path to the clinic and beyond. Let’s talk about how Resilience’s cutting-edge solutions can support your Biologics journey. Book a meeting with us: https://hubs.ly/Q03fh9Cj0 #BioUS25 #GenerisBIO

Your goal is our goal: to get your cell therapy innovation to more patients, sooner. With the Auto-T™ cell therapy manufacturing platform from Resilience, get your LVV-based autologous CAR-T and TCR products into clinical trials in less than 1 year. All core unit operations have been developed, functionally closed, and featured in multiple INDs. When every single day matters to the patients waiting for your innovation, what are you waiting for? Connect with our cell therapy team today to see if Auto-T is the right match for your innovation. #celltherapy

The CDMO landscape is evolving, who will be at the forefront of innovation? Susan Billings, Ph.D, Resilience’s Chief Commercial Officer, sat down with Drug Development & Delivery to discuss how Resilience is committed to ensuring uninterrupted access to life-saving therapies. From pioneering biomanufacturing solutions to reshaping supply chain resilience, read the interview to learn which cutting-edge technologies and strategic investments are needed to meet industry demands. Read more on the blog. #Biomanufacturing #CDMO #Innovation

In CAR-T cell therapy, time is always of the essence – to your patients, your product teams, and your partners. What happens when you cut down the manufacturing time down to just 3 days? Discover our 3-Day Short Cycle CAR-T Manufacturing process, which capitalizes on the potency and persistence of both naive and central memory T cells by reading our latest white paper: https://hubs.ly/Q03bQXM90 Interested in exploring how we can support your autologous CAR-T cell therapy? Put this technology to work with our DAR-T offering. Learn more: https://hubs.ly/Q03bRgyf0.   #CART #CellTherapy #WhitePaper

We’re pleased to share that Resilience is expanding into a 190,000 sq. ft. facility in Blue Ash, OH, adding highly automated Device Assembly & Packaging capabilities for Drug Product filled at the West Chester, OH, site and increasing cold and ambient storage. This expansion supports our commitment to expand drug product capabilities to meet growing industry demands and will help grow our Cincinnati workforce to nearly 1,000 employees. Thank you to our partners at JobsOhio and REDI Cincinnati for making this expansion possible! #Resilience #DrugProduct #Innovation

Cultivating a flourishing manufacturing partnership is key. And discovering a partner that will not only support and nurture your product’s growth, but also empower you through the process, is an added bonus. As you search for your next drug product or fill/finish CDMO, we invite you to take our innovative questionnaire, which will deliver a list of personalized resources to help guide you through your next phase. Sprout Solutions for your drug product – designed to bloom in every season. Take the questionnaire today: https://hubs.ly/Q0361kQ90

Modernize your CAR-T cell therapy’s characterization toolbox with Kona Multiomics Characterization Assay Services. Using Kona Multiomics Assay, you’ll access a wealth of information that can deepen your understanding of your drug product and contribute to better therapeutic potential. See the data for yourself and download the fact sheet today: https://hubs.ly/Q037qYxX0

Thanks to all who met with us during #DCATWeek! We enjoyed connecting with so many of you throughout the week. We look forward to continuing conversations and strengthening partnerships to pursue a more resilient tomorrow, today. We are grateful to DCAT (Drug, Chemical & Associated Technologies Association) for hosting a great event this week.